Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:61-66
Published online before print October 30, 2003, doi: 10.1161/01.ATV.0000104014.24367.16
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/1/61    most recent
01.ATV.0000104014.24367.16v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, T. N.
Right arrow Articles by Huang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, T. N.
Right arrow Articles by Huang, Y.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:61.)
© 2004 American Heart Association, Inc.


Vascular Biology

C-Reactive Protein Stimulates MMP-1 Expression in U937 Histiocytes Through Fc{gamma}RII and Extracellular Signal-Regulated Kinase Pathway:

An Implication of CRP Involvement in Plaque Destabilization

Takeyla N. Williams; Cecelia X. Zhang; Bryan A. Game; Lin He; Yan Huang

From the Ralph H. Johnson Veterans Affairs Medical Center and Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine Medical University of South Carolina, Charleston, SC.

Correspondence to Yan Huang, MD, PhD, Ralph H. Johnson Veterans Affairs Medical Center and Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, 114 Doughty St, Charleston, SC 29403. E-mail huangyan{at}musc.edu

Objective— It has been shown that plasma level of C-reactive protein (CRP) is an independent predictor for acute coronary syndromes and is associated with plaque weakening. However, the underlying mechanisms are not well understood. In this study, we investigated the effect of CRP on the expression of matrix metalloproteinase-1 (MMP-1) that has been implicated in plaque vulnerability by human U937 histiocytes and monocyte-derived macrophages.

Methods and Results— Enzyme-linked immunosorbent assay of MMP-1 in conditioned medium showed that treatment of U937 cells with 100 µg/mL of CRP for 24 hour led to a 3- to 5-fold increase in MMP-1 secretion. CRP also markedly stimulated MMP-1 release from human monocyte-derived macrophages. In contrast, CRP had no effect on tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. Northern blot showed that CRP upregulated MMP-1 mRNA expression. Collagenase activity assay showed that CRP increased collagen-degrading activity in cell-conditioned medium. Furthermore, results showed that the stimulation of MMP-1 secretion by CRP was inhibited by anti-CD32, but not by anti-CD64 antibody, and by mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) inhibitor PD98059. Finally, Western blot showed that CRP stimulated phosphorylation of extracellular signal-regulated kinase.

Conclusions— This study demonstrates that CRP stimulates MMP-1 expression by U937 cells through Fc{gamma}RII and extracellular signal-regulated kinase pathway. These findings suggest that CRP may promote matrix degradation and thus contribute to plaque vulnerability.


Key Words: C-reactive protein • matrix metalloproteinase • arteriosclerosis • gene expression




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Devaraj, J.-M. Yun, C. Duncan-Staley, and I. Jialal
C-reactive protein induces M-CSF release and macrophage proliferation
J. Leukoc. Biol., February 1, 2009; 85(2): 262 - 267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion
J. Immunol., July 15, 2008; 181(2): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. Singh, M. R. Dasu, P. G. Yancey, A. Afify, S. Devaraj, and I. Jialal
Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats
J. Lipid Res., May 1, 2008; 49(5): 1015 - 1023.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. A. Lange, C. S. Carlson, L. A. Hindorff, E. M. Lange, J. Walston, J. P. Durda, M. Cushman, J. C. Bis, D. Zeng, D. Lin, et al.
Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
JAMA, December 13, 2006; 296(22): 2703 - 2711.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. T. Johnson, K. E. Betts, M. J. Radeke, G. S. Hageman, D. H. Anderson, and L. V. Johnson
Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid
PNAS, November 14, 2006; 103(46): 17456 - 17461.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Singh, S. Devaraj, M. R. Dasu, D. Ciobanu, J. Reusch, and I. Jialal
C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2469 - 2475.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Krupinski, M. M. Turu, J. Martinez-Gonzalez, A. Carvajal, J. O. Juan-Babot, E. Iborra, M. Slevin, F. Rubio, and L. Badimon
Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
Stroke, May 1, 2006; 37(5): 1200 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Montero, J. Orbe, N. Varo, O. Beloqui, J. I. Monreal, J. A. Rodriguez, J. Diez, P. Libby, and J. A. Paramo
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells: Implications for Clinical and Subclinical Atherosclerosis
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Jialal, S. Devaraj, and U. Singh
C-Reactive Protein and the Vascular Endothelium: Implications for Plaque Instability
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1379 - 1381.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Zhang and L. M. Wahl
Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2
J. Leukoc. Biol., January 1, 2006; 79(1): 105 - 113.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S G Baidya and Q-T Zeng
Helper T cells and atherosclerosis: the cytokine web
Postgrad. Med. J., December 1, 2005; 81(962): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Nakakuki, M. Ito, H. Iwasaki, Y. Kureishi, R. Okamoto, N. Moriki, M. Kongo, S. Kato, N. Yamada, N. Isaka, et al.
Rho/Rho-Kinase Pathway Contributes to C-Reactive Protein-Induced Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2088 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Devaraj, T. W. Du Clos, and I. Jialal
Binding and Internalization of C-Reactive Protein by Fcgamma Receptors on Human Aortic Endothelial Cells Mediates Biological Effects
Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1359 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Wang, X. Zhu, Q. Xu, X. Ding, Y. E. Chen, and Q. Song
Effect of C-reactive protein on gene expression in vascular endothelial cells
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1539 - H1545.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
J. Lipid Res., March 1, 2005; 46(3): 389 - 403.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman
Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques
Stroke, January 1, 2005; 36(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-Z. Kong, X.-R. Huang, X. Ouyang, J.-J. Tan, G. Fingerle-Rowson, M. Bacher, W. Mu, L. A. Scher, L. Leng, R. Bucala, et al.
Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques
Cardiovasc Res, January 1, 2005; 65(1): 272 - 282.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Jialal, S. Devaraj, and S. K. Venugopal
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Hypertension, July 1, 2004; 44(1): 6 - 11.
[Abstract] [Full Text] [PDF]